Implications of Methylation Patterns of Cancer Genes in Salivary Gland Tumors
- 15 December 2006
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (24) , 7353-7358
Abstract
Purpose: We investigated the methylation status and protein expression of four tumor suppressor genes to determine their role in salivary gland tumorigenesis. Experimental Design: We performed methylation-specific PCR and protein analyses of 29 normal salivary glands, 23 benign, and 79 malignant salivary gland neoplasms to determine the pattern and potential diagnostic and/or biological role of the RASSF1, RARβ2, DAPK, and MGMT tumor suppressor gene methylation in these tumors. Results: No methylation was detected in the normal tissues. Methylation occurred in 9 of 23 (39.1%) benign tumors; 3 (25.0%) pleomorphic adenomas and 6 (66.7%) Warthin's tumors at the MGMT, DAPK, or RASSF1 genes. Methylation occurred in 33 of 79 (41.8%) malignant tumors; 8 (30.8%) adenoid cystic carcinomas, 6 (33.3%) mucoepidermoid carcinomas, 6 (42.9%) acinic cell carcinomas, and 13 (62.0%) salivary duct carcinomas. RASSF1 and RARβ2 represented 75.8% of methylation events occurring most frequently in salivary duct and acinic cell carcinomas. Overall, we found no significant correlation between protein expression and methylation status of individual genes, but observed low or absent protein expression in several methylated tumors. Significant correlations were found between methylation and aggressive malignant phenotypes (P = 0.0004) and age (P = 0.05). Conclusions: (a) Benign and malignant salivary tumors differed in the frequency and pattern of gene methylation; (b) high-grade carcinomas were significantly methylated compared with low-grade phenotypes; (c) RASSF1 and RARβ2 were highly methylated in malignant tumors and can be targeted for therapy; and (d) methylation pattern may serve as a diagnostic and biological marker in assessing these tumors.Keywords
This publication has 44 references indexed in Scilit:
- Epigenetic Changes in Solid and Hematopoietic TumorsSeminars in Oncology, 2005
- Promoter Hypermethylation Profile of Kidney CancerClinical Cancer Research, 2004
- Promoter methylation and protein expression of the E-cadherin gene in the clinicopathologic assessment of adenoid cystic carcinomaLaboratory Investigation, 2004
- Expression of p16 Protein and Hypermethylation Status of Its Promoter Gene in Adenoid Cystic Carcinoma of the Head and NeckORL, 2003
- The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 AccumulationMolecular and Cellular Biology, 2002
- Mucoepidermoid Carcinoma Involving Warthin TumorAmerican Journal of Clinical Pathology, 2000
- Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung CarcinomasJNCI: Journal of the National Cancer Institute, 2000
- RARβ2 specificity in mediating RA inhibition of growth of lung cancer-derived cellsLung Cancer, 2000
- Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colonNature Genetics, 1994
- Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signalingEndocrine Reviews, 1994